July 29 (Reuters) - Eli Lilly and Co LLY.N:
LTZ THERAPEUTICS ANNOUNCES STRATEGIC COLLABORATION WITH ELI LILLY TO ADVANCE DEVELOPMENT OF ITS MYELOID ENGAGER PLATFORM FOR AUTOIMMUNE DISEASES
LTZ THERAPEUTICS: UNDER TERMS OF AGREEMENT, LTZ WILL RECEIVE A DOUBLE-DIGIT MILLION USD UPFRONT PAYMENT AND AN EQUITY INVESTMENT IN COMPANY